Pentracor GmbH
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19 (NCT04898062) | Pentracor GmbH | 2021-05-05 |
| CASTRO1 - Study on CRP Apheresis After Ischemic Stroke (NCT04417231) | Pentracor GmbH | 2021-01-28 |
| Study on CRP Apheresis After Coronary Bypass Surgery (NCT04745468) | Pentracor GmbH | 2018-03-21 |
Track Pentracor GmbH automatically
Every clearance here is in the API, with alerts when new ones post.